FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GOLDEN GENESIS Ltd

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/9/2011 

3. Issuer Name and Ticker or Trading Symbol

Tanke Biosciences Corp [TNBI]

(Last)        (First)        (Middle)

ROOM 2801, EAST TOWER HUI HAO BUILDING, NO. 519 MACHANG ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

PEARL RIVER NEW CITY,GUANGZHOU, F4 510627       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Call Option (obligation to sell)   12/31/2011   12/31/2016   Common Stock, par value $0.001 per share   3403899   $0.01   D   (1)  
Call Option (obligation to sell)   12/31/2012   12/31/2017   Common Stock, par value $0.001 per share   3303785   $0.01   D   (1)  
Call Option (obligation to sell)   12/31/2013   12/31/2018   Common Stock, par value $0.001 per share   3303785   $0.01   D   (1)  

Explanation of Responses:
( 1)  Golden Genesis Limited ("Golden Genesis") is the holder of an aggregate of 8,011,469 shares of common stock issued in its name that shall be transferred within the next 3 years to Guixiong Qiu, Bi Gao, Xiuzhen Liang and Bing Teng (collectively, the "Tanke Shareholders") in accordance with a Call Option Agreement. Pursuant to the Call Option Agreement, Golden Genesis has agreed not to exercise any of its voting rights with respect to such shares on behalf of the Tanke Shareholders without the prior written consent of the Tanke Shareholders. (continues below)

Remarks:
(continued from above) Golden Genesis is also the holder of an aggregate of 2,000,000 shares of common stock over which the Tanke Shareholders have voting power that are issued in the name of Golden Genesis, but held in escrow pursuant to the terms of a Securities Escrow Agreement, which provides that an aggregate of 1,000,000 shares will be disbursed in each of 2012 and 2013 to either the investors in a private placement of securities of the issuer consummated on February 9, 2011, on a pro rata basis, or to Golden Genesis (and, subsequently, to the Tanke Shareholders, on a pro rata basis, pursuant to the Call Option Agreement), based on whether the issuer achieves certain financial benchmarks for the fiscal years ending December 31, 2011 and 2012. Please refer to the issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on February 10, 2011 for more information on these agreements.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GOLDEN GENESIS Ltd
ROOM 2801, EAST TOWER HUI HAO BUILDING
NO. 519 MACHANG ROAD
PEARL RIVER NEW CITY,GUANGZHOU, F4 510627
X


Signatures
/s/ Golden Genesis Limited 2/24/2011
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Grafico Azioni Tanke Biosciences (PK) (USOTC:TNBI)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Tanke Biosciences (PK)
Grafico Azioni Tanke Biosciences (PK) (USOTC:TNBI)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Tanke Biosciences (PK)